Natural killer cells in hepatitis C virus infection

Federica Bozzano, Francesco Marras, Roberto Biassoni, Andrea De Maria

Research output: Contribution to journalArticlepeer-review


Hepatitis C virus (HCV) infection induces the long-term risk of liver cirrhosis or hepatocellular carcinoma and in adults represents the most common cause of liver transplantation. Natural killer (NK) cells participate in innate immune responses with efficient direct antitumor and antiviral defense. Over the years, their complex interaction with downstream adaptive responses and with the regulation of immune responses has been increasingly recognized. Considerable advances have been made particularly in understanding the role of NK cells in the pathophysiology of HCV infection and their possible use as biological markers for clinical purposes. This review summarizes the available data on the role of NK cells in the natural history of HCV infection and their role in the outcome of treatment. The main objective of this review is to summarize recent advancements in the basic understanding of NK cell function highlighting their possible translational use in clinical practice. An integrated practical view on the possible use of currently available predictive immunogenetic and NK cell functional tests is provided, to support clinical management choices for optimal treatment of patients with both standard and new drug regimens.

Original languageEnglish
Pages (from-to)775-788
Number of pages14
JournalExpert Review of Clinical Immunology
Issue number8
Publication statusPublished - Nov 2012


  • directly acting antivirals
  • HCV
  • HLA
  • IFN-α
  • IFN-λ
  • IL-28B
  • KIR
  • natural cytotoxicity receptors
  • NK cell
  • protease inhibitors
  • standard treatment
  • treatment outcome

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'Natural killer cells in hepatitis C virus infection'. Together they form a unique fingerprint.

Cite this